Skip to main content Skip to secondary navigation
Journal Article

Willingness to Participate in Clinical Research Among Individuals With Cognitive Impairment

This secondary analysis examined (1) factors associated with willingness to participate in clinical research for cognitive health among individuals with cognitive impairment and their care partners, and (2) concordance regarding such willingness between individuals with cognitive impairment and their care partners (dyads). Neuropsychological factors and willingness to participate in clinical research were collected using self-reported questionnaires. Participants' sociodemographic and clinical information was extracted from the University of Pittsburgh Alzheimer's Disease Research Center record. Binary logistic regression and Cohen's kappa coefficient analyses were performed. Greater trust in medical researchers (p = 0.031, B = 0.127) and more severe cognitive impairment (p = 0.009, B = ?0.289) were associated with willingness to participate in clinical research among individuals with cognitive impairment. Dyadic agreement on willingness to have the individual with cognitive impairment enroll in clinical research was poor to fair (? = 0.380). Findings suggest that individuals with cognitive impairment with greater trust in health professionals are more likely to agree to clinical research participation. Nurses and other health care providers who counsel individuals with cognitive impairment and their care partners should work to build trusting relationships with participants and be mindful of how increased trust can alter power dynamics between participants and health care professionals. [Research in Gerontological Nursing, xx(x), xx?xx.]In the United States, cognitive disorders, including Alzheimer's disease, affect 11% of people aged ?65 years (Hudomiet et al., 2018). However, interventions for effectively treating cognitive impairment are limited, and [...]

Author(s)
M. Li
H. Kim
S.M. Sereika
T.J. Nissley
J.H. Lingler
Journal Name
Slack, Inc.
Publication Date
February 2, 2022